Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

Clinical studies, with a distinct focus on treatment resistant depression, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Treatment Resistant Depression Depressive Disorder Depressive Disorder, Treatment-Resistant Mental Disorders Mood Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of treatment resistant depression
Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
No prior treatment for treatment resistant depression

Exclusion criteria

Enrolled in another research study
Inability to provide written informed consent
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Treatment and study plan

Primary outcomes

Rate of patients who decide to enroll in a treatment resistant depression clinical research.

Time frame: 3 months
Number of treatment resistant depression study participants who remain in clinical study until completion.

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

4159004227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Evaluating the Occurrence of Engagement Patterns and Participation Trends Among Patients in Treatment Resistant Depression

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Oct 26, 2023
Registry last updated: Oct 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting